Moreover, the addition of rh-MCP-1 rescued the inhibition of melanoma cell migration as opposed to those cells that migrated in the presence of bindarit-treated astrocytes (P = 0.006) or toward the CM of bindarit-treated astrocytes (P = 0.115) (Figure 2F and Supplemental Figure 11C). This evidence concerns the gene CCL2 and melanoma.